QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
OTCMKTS:ICOTF

iCo Therapeutics (ICOTF) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free ICOTF Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.39
▼
$0.39
50-Day Range
$0.30
▼
$0.42
52-Week Range
$0.80
▼
$1.82
Volume
1,000 shs
Average Volume
4,760 shs
Market Capitalization
$3.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
ICOTF stock logo

About iCo Therapeutics Stock (OTCMKTS:ICOTF)

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada.

ICOTF Stock News Headlines

May 10, 2023 | wsj.com
ICO Group Ltd.
February 25, 2023 | marketwatch.com
Antisense & RNAi Therapeutics Market 2023 Estimated to Perceive Exponential Growth till 2028
April 19, 2024 | Behind the Markets (Ad)
The #1 Opportunity of the decade?
It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.
February 19, 2023 | finance.yahoo.com
Women's health therapeutics market size to increase by USD 30.35 billion: North America to account for 37% of market growth - Technavio
February 19, 2023 | seekingalpha.com
Jasper Therapeutics releases promising early-stage data on sickle cell disease treatment
October 10, 2022 | usnews.com
Consumers to Ditch Cafes for Coffee at Home Amid Rising Prices, Says ICO
August 16, 2022 | investing.com
Satellos Bioscience Inc (MSCL)
June 1, 2022 | seekingalpha.com
Satellos Bioscience GAAP EPS of -C$0.06
April 19, 2024 | Behind the Markets (Ad)
The #1 Opportunity of the decade?
It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.
December 16, 2021 | finance.yahoo.com
Satellos Bioscience Inc. Announces Scientific Research Agreement with Université de Sherbrooke to Study Rare Muscular Dystrophies
December 15, 2021 | finance.yahoo.com
Satellos Bioscience to Webcast Live at Life Sciences Investor Forum December 16th
December 9, 2021 | finance.yahoo.com
ICOTF: Targeting Stem Cells for Muscular Dystrophy Treatment
December 6, 2021 | finance.yahoo.com
Satellos Bioscience Announces New Board Appointments
December 2, 2021 | investing.com
iCo Therapeutics Inc (MSCL)
November 29, 2021 | finance.yahoo.com
Satellos Bioscience Reports Third Quarter 2021 Financial Results and Operational Highlights
October 27, 2021 | finance.yahoo.com
Satellos Bioscience Inc. Retains BND Projects Inc. for Strategic Investor Relations Services
August 5, 2021 | finance.yahoo.com
iCo Therapeutics Inc. Announces Shareholder Approval of Business Combination with Satellos Bioscience Inc.
See More Headlines
Receive ICOTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iCo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:ICOTF
CUSIP
N/A
CIK
N/A
Web
www.icotherapeutics.com
Phone
(905) 336-6128
Fax
604-602-9699
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.40)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,110,000.00
Net Margins
N/A
Pretax Margin
-4,148.78%
Return on Equity
N/A
Return on Assets
-288.85%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.72
Quick Ratio
0.72

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.07) per share
Price / Book
-5.57

Miscellaneous

Outstanding Shares
9,054,000
Free Float
N/A
Market Cap
$3.53 million
Optionable
Not Optionable
Beta
2.03
Metaverse Stocks And Why You Can't Ignore Them Cover
Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Frank Gleeson
    President & Chief Executive Officer
  • Warren Whitehead
    Chief Financial Officer
  • Michael Rudnicki
    Chief Scientific Officer
  • J. Robert Hall
    Vice President-Finance & Administration

Key Competitors

View All Competitors

This page (OTCMKTS:ICOTF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
How Biden has already won 2024
Porter & Company
Urgent alert: open this for a huge profit potential
Timothy Sykes